{
  "context": {
    "rules": [
      "Rule1: Provided that alcohol is approved for the platform, then the product becomes market available.",
      "Rule2: Either alcohol is approved for the platform or substance is approved for the platform.",
      "Rule3: A drug has emergency use authorization or it has conditional approval.",
      "Rule4: If a drug has conditional approval, then it does not require clinical trials.",
      "Rule5: When an application for alcohol is submitted, the outcome is either fast-track approval for the drug or, assuming therapeutic benefit, absence of addictive property in substance.",
      "Rule6: An application has been submitted for alcohol or one has been submitted for substance.",
      "Rule7: If the implication that emergency use authorization negates the need for clinical trials does not hold, then the drug faces regulatory investigation.",
      "Rule8: In the situation where emergency use authorization failing to waive clinical trials occurs, regulatory investigation does not follow.",
      "Rule9: Whenever the approval of substance for the platform does not lead to market availability, the drug requires clinical trials.",
      "Rule10: Provided that it is not the case that the drug is approved for research or exempt from clinical trials, then the drug is a banned substance.",
      "Rule11: If the failure of the implication that substance's application submission leads to fast-track approval or non-addictive therapeutic benefit does not result in application rejection, then an appeal is filed for substance.",
      "Rule12: Under the condition that the non-implication of substance's application submission to approval paths not causing rejection, an appeal is not filed for substance.",
      "Rule13: In the event the product is not market available, substance has an addictive property."
    ],
    "facts": [
      "Fact1: A drug has therapeutic benefit.",
      "Fact2: It is not the case that the application for substance is rejected.",
      "Fact3: A drug is not approved for research.",
      "Fact4: A drug is not a banned substance.",
      "Fact5: A drug does not qualify for fast-track approval."
    ]
  },
  "question": "A product is market available."
}